GelStat Corp. (OTCMKTS:GSAC – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totaling 3,449 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 916,991 shares, the short-interest ratio is currently 0.0 days.
GelStat Price Performance
Shares of GelStat stock remained flat at $0.00 during trading hours on Friday. GelStat has a twelve month low of $0.00 and a twelve month high of $0.00.
GelStat Company Profile
GelStat Corporation is a specialty healthcare company associated with the development and marketing of over-the-counter products intended to address common health conditions. The company is best known for GelStat Migraine, a nonprescription product marketed for the temporary relief of migraine-related symptoms.
Historically, GelStat’s product portfolio also included other consumer healthcare offerings, including products positioned for sleep support and relief from cold-related symptoms.
Further Reading
- Five stocks we like better than GelStat
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for GelStat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GelStat and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}